Lexeo Therapeutics, Inc.

Historical 13F Holders

Symbol
LXEO
CUSIP
52886X107
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 92 28.0 M $100 M
2024 Q4 91 29.5 M $194 M
2024 Q3 72 29.8 M $270 M
2024 Q2 62 26.6 M $426 M
2024 Q1 58 23.2 M $362 M
2023 Q4 34 16.2 M $217 M